As your pharmaceutical company builds and deploys serialization and track and trace capabilities to support the EU Falsified Medicines Directive (EU FMD), the challenge of managing all your requirements and specifications will become more and more complex. And time-consuming. 

To help you prepare, we asked select EU serialization experts to share their views and lessons learned about overcoming implementation hurdles.

Learn:     

• How frontrunners across Germany, Spain, Scandinavia, and Italy are addressing EU FMD.
• What the biggest roadblocks are right now.
• What makes implementing Level 1-Level 5 so complex.
• How you can improve compliance outcomes as the February 9, 2019, deadline gets closer.